Literature DB >> 32079084

Dietary Behaviors and Metabolic Syndrome in Schizophrenia Patients.

Katarzyna Adamowicz1, Jolanta Kucharska-Mazur1.   

Abstract

The metabolic syndrome (MS) is highly prevalent in schizophrenia patients, resulting from both pharmacotherapy and their lifestyle. To avoid its development, the analysis of patients' eating behaviors followed by the necessary nutritional changes should become a routine element of treatment. The aim of this study is to investigate the effect of dietary habits on the course of schizophrenia and MS, cognitive performance, symptom severity, and subjective assessment of eating behaviors in schizophrenia patients. Total of 87 participants (63.2% women) aged 19 to 67 years (M = 41.67; SD = 12.87), of whom 60 met the IDF criteria for MS, completed the PANSS, the verbal fluency test, the Stroop Color-Word Test, and the digit span task, followed by a thorough nutritional interview. There were no significant differences in the dietary behaviors between investigated schizophrenia patients with and without comorbid MS. Interestingly, their eating habits compared quite favorably to those described in the literature. No associations were found between positive eating habits and other tested variables in patients with MS. They were, however, linked to lower PANSS scores in the entire sample. In addition, positive eating habits correlated with better cognitive performance and a more adequate subjective assessment of dietary habits. It would be amiss to assume that schizophrenia patients lack the ability to control their eating behaviors. Nutrition education may foster desirable dietary changes and improve the sense of agency, thus helping to reduce symptom severity and enhancing cognitive performance in this patient population.

Entities:  

Keywords:  cognitive performance; eating behaviors; metabolic syndrome; schizophrenia; self-awareness

Year:  2020        PMID: 32079084     DOI: 10.3390/jcm9020537

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  4 in total

1.  The Deficit Schizophrenia Subtype Is Associated with Low Adherence to the Mediterranean Diet: Findings from a Case-Control Study.

Authors:  Krzysztof Kowalski; Bogna Bogudzińska; Bartłomiej Stańczykiewicz; Patryk Piotrowski; Tomasz Bielawski; Jerzy Samochowiec; Krzysztof Szczygieł; Piotr Plichta; Błażej Misiak
Journal:  J Clin Med       Date:  2022-01-23       Impact factor: 4.241

Review 2.  Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction.

Authors:  Kah Kheng Goh; Cynthia Yi-An Chen; Tzu-Hua Wu; Chun-Hsin Chen; Mong-Liang Lu
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

3.  Antipsychotic Drug Aripiprazole Protects Liver Cells from Oxidative Stress.

Authors:  Barbara Kramar; Tinkara Pirc Marolt; Maria Monsalve; Dušan Šuput; Irina Milisav
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

4.  Metabolic Syndrome and Dietary Habits in Hospitalized Patients with Schizophrenia: A Cross-Sectional Study.

Authors:  Tamara Sorić; Mladen Mavar; Ivana Rumbak
Journal:  Medicina (Kaunas)       Date:  2021-03-10       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.